Literature DB >> 9701105

Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults.

M A Gardam1, D E Low, R Saginur, M A Miller.   

Abstract

Necrotizing fasciitis, which is a severe and uncommon infection involving the subcutaneous tissues, is usually caused by group A streptococci. To our knowledge, however, group B streptococci (Streptococcus agalactiae) have been reported to cause necrotizing fasciitis in only 4 instances (2 involving neonates) over the past 4 decades. We report 3 cases of group B streptococcal necrotizing fasciitis in adults that occurred in southern Ontario and Quebec within a 10-month period. All 3 patients had significant underlying illness, and all required surgical debridement in addition to antibiotic therapy. One of the cases fulfilled the criteria for streptococcal toxic shock-like syndrome. Group B streptococcus has been recognized as a frequent cause of serious disease in adults. It has become evident over the past decade that invasive streptococcal infections are on the increase. We speculate that group B streptococcus has recently acquired an increased ability to cause necrotizing fasciitis and suggest that this may represent the emergence of a new clinical syndrome in adults.

Entities:  

Mesh:

Year:  1998        PMID: 9701105     DOI: 10.1001/archinte.158.15.1704

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  21 in total

1.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius.

Authors:  K P Dierksen; N L Ragland; J R Tagg
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Group B Streptococcus necrotizing fasciitis: an emerging disease?

Authors:  C-H Wong; A Kurup; K-C Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-16       Impact factor: 3.267

Review 4.  Group B streptococcal toxic shock syndrome in an asplenic patient: case report and literature review.

Authors:  K D Sims; T D Barton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

5.  Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.

Authors:  Sezgin Erdogan; Peter K Fagan; Susanne R Talay; Manfred Rohde; Patricia Ferrieri; Aurea E Flores; Carlos A Guzmán; Mark J Walker; Gursharan S Chhatwal
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.

Authors:  Luciana Tissi; Manuela Puliti; Francesco Bistoni; Paolo Mosci; Thomas R Kozel; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Severity of group B streptococcal arthritis in selected strains of laboratory mice.

Authors:  M Puliti; F Bistoni; C von Hunolstein; G Orefici; L Tissi
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.

Authors:  Manuela Puliti; Christina von Hunolstein; Francesco Bistoni; Graziella Orefici; Luciana Tissi
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Necrotizing Soft Tissue Infections.

Authors:  Thomas M. File
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

10.  IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection.

Authors:  Luciana Tissi; Francesco Bistoni; Manuela Puliti
Journal:  Mediators Inflamm       Date:  2009-07-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.